Trademark Search in Canada

PIONEERING EXONEURAL BIOLOGY

View On IC.GC.CA

CANCELLED

Last Applicant/ Owned by

CYGNAL THERAPEUTICS INC.

325 Vassar Street, Suite 2BCambridge MA 02139

Serial Number

2116499 filed on 25^th Apr 2021

Registration Number

TMA1138896 registered on 17^th Aug 2022

Registration expiry Date

25^th Apr 2031

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

K1P5W3

PIONEERING EXONEURAL BIOLOGY

Trademark usage description

pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and deve Read More

Classification Information

Class [042]
Pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals.

Classification kind code

Mark Details

Serial Number

2116499

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 9^th Mar 2022	Approval Notice Sent
Submitted for opposition 22 on 25^th Oct 2021	Search Recorded
Submitted for opposition 20 on 25^th Oct 2021	Examiner's First Report
Submitted for opposition 223 on 25^th Oct 2021	Total Provisional Refusal
Submitted for opposition 48 on 19^th Oct 2021	Agent Changed
Submitted for opposition 257 on 24^th Jun 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 23^rd Jun 2021	Created
Submitted for opposition 31 on 23^rd Jun 2021	Formalized
Submitted for opposition 30 on 25^th Apr 2021	Filed
Submitted for opposition 228 on 25^th Apr 2021	International Registration